EUVIMEDEUVIMED entdecken
Crossref

Controlled Boc-Protection of Diketopiperazine Using Tributylphosphine

Tomohiro Hattori, Kazumasa Kon, Yuki Matsunaga, Hisashi Yamamoto

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Tomohiro Hattori und 3 weiteren Autor:innen. Beteiligte Einrichtung: Peptide Research Center, Chubu University, 1200 Matsumoto-cho, Kasugai, Aichi 487-8501, Japan. Hauptthemen laut MEDLINE: Diketopiperazines, Phosphines, Methylamines, Pyridines. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiketopiperazinesPhosphinesMethylaminesPyridinesAcylationAmino AcidsMolecular Structure

Stichwörter der Autor:innen

acylationdiketopiprazineelongationtert-butoxycarbonyl protection

Substanzen

Amino AcidsDiketopiperazinesPhosphines4-N,N-dimethylaminopyridineMethylaminesPyridines

Autor:innen und Institutionen

  • Peptide Research Center, Chubu University, 1200 Matsumoto-cho, Kasugai, Aichi 487-8501, Japan.
  • Department of Chemistry, Graduate School of Science, Chiba University, 1-33 Yayoi, Inage, Chiba 263-8522, Japan.

Zitieren

APA

Hattori, T., Kon, K., Matsunaga, Y., & Yamamoto, H. (2025). Controlled Boc-Protection of Diketopiperazine Using Tributylphosphine. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00426

Vancouver

Hattori T, Kon K, Matsunaga Y, Yamamoto H. Controlled Boc-Protection of Diketopiperazine Using Tributylphosphine. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00426

BibTeX
@article{Hattori2025,
  author = {Hattori, Tomohiro and Kon, Kazumasa and Matsunaga, Yuki and Yamamoto, Hisashi},
  title = {Controlled Boc-Protection of Diketopiperazine Using Tributylphosphine},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00426}
}
Kostenlos starten →